bluebird bio Inc (NASDAQ:BLUE)
| 46.03 Delayed Data As of Jan 26 |  -2.03 / -4.22%Today’s Change | 38.95 Today|||52-Week Range 94.50 | +6.38% Year-to-Date |
Latest BLUE News | Press Releases
| 3 Stocks Wall Street Thinks Will Soar 50% or More in 2021 Jan 24 / MotleyFool.com - Paid Partner Content | Here's Why Bristol Myers Squibb's Partners Think 2021 Could Be Prosperous Jan 19 / MotleyFool.com - Paid Partner Content |
| New Strong Sell Stocks for January 21st Jan 21 / Zacks.com - Paid Partner Content | Harpoon's (HARP) Multiple Myeloma Candidate Gets Orphan Drug Tag Jan 14 / Zacks.com - Paid Partner Content |
| Why Verastem Stock Sank Today Jan 20 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 48.10 |
| Today’s open | 48.25 |
| Day’s range | 45.60 - 48.40 |
| Volume | 1,129,626 |
| Average volume (3 months) | 1,031,707 |
| Market cap | $3.1B |
Data as of 4:00pm ET, 01/26/2021
Growth & Valuation
| Earnings growth (last year) | -33.98% |
| Earnings growth (this year) | +30.84% |
| Earnings growth (next 5 years) | -64.66% |
| Revenue growth (last year) | -18.15% |
| P/E ratio | NM |
| Price/Sales | 108.41 |
| Price/Book | 2.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NSTGNanoString Technolog... | -8.07 | -10.48% |
| RCKTRocket Pharmaceutica... | -3.35 | -5.88% |
| NKTRNektar Therapeutics | +0.50 | +2.82% |
| XNCRXencor Inc | -0.01 | -0.02% |
Data as of 4:00pm ET, 01/26/2021
Financials
| Next reporting date | March 1, 2021 |
| EPS forecast (this quarter) | -$2.95 |
| Annual revenue (last year) | $44.7M |
| Annual profit (last year) | -$789.6M |
| Net profit margin | -1,767.49% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
